▮ More

EARNINGS SUMMARY: Details of VOXX International Corporation Q4 Earnings Report

By RTTNews Staff Writer ✉ | Published: 5/13/2021 5:23 PM ET

Below are the earnings highlights for VOXX International Corporation (VOXX):

-Earnings: $9.4 million in Q4 vs. -$21.8 million in the same period last year.
-EPS: $0.38 in Q4 vs. -$0.90 in the same period last year.
-Revenue: $162.5 million in Q4 vs. $101.1 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In March 2023

Latest Updates on COVID-19

FDA Approves Pfizer's COVID-19 Pill Paxlovid

US Revokes Covid Vaccination Requirement For International Air Travel

COVID-19: Drugs in Development

Follow RTT

Editor's Pick
Most Read
Most Emailed

Inditex Stock Up On Q1 Profit Growth; Sees Flat Margin In FY23

CPSC Warns Against Recalled Boppy Newborn Loungers After More Infant Deaths

Apple Unveils Vision Pro Headset, IOS 17, 15-inch MacBook Air And More

Domino's Offers 50% Off Online Deal Through June 11

Frozen RTE Beef Chili Products Supplied Through NSLP Recalled

Boeing, NASA Further Delay Starliner Crew Flight Launch

Chervon Recalls EGO Power+ Cordless Brushless Hedge Trimmers

E.N.A. Meat Packing Recalls Frozen, Raw Lamb Products

Dechra Pharma Agrees To Be Acquired By EQT's Freya Bidco For 3,875p/share In Cash

EARNINGS SUMMARY: Details of VOXX International Corporation Q4 Earnings Report

Inditex Stock Up On Q1 Profit Growth; Sees Flat Margin In FY23

CPSC Warns Against Recalled Boppy Newborn Loungers After More Infant Deaths

Apple Unveils Vision Pro Headset, IOS 17, 15-inch MacBook Air And More

Domino's Offers 50% Off Online Deal Through June 11

Frozen RTE Beef Chili Products Supplied Through NSLP Recalled

Boeing, NASA Further Delay Starliner Crew Flight Launch

Chervon Recalls EGO Power+ Cordless Brushless Hedge Trimmers

E.N.A. Meat Packing Recalls Frozen, Raw Lamb Products

Dechra Pharma Agrees To Be Acquired By EQT's Freya Bidco For 3,875p/share In Cash

AstraZeneca Reports Positive Results From Interim Analysis Of DESTINY-PanTumor02 Phase II Trial

Novartis Says Kisqali And Endocrine Therapy Reduces Cancer Recurrence Risk By 25%

Novavax Signs Deal With Bill & Melinda Gates Research Institute To Provide Matrix-M Adjuvant

MorphoSys To Release Myelofibrosis Trial Data This Year

MEI Pharma Promotes COO David Urso To Succeed Daniel Gold As President And CEO

Evotec Gets $1.7 Mln Grant For Discovery Of RNA-targeting Henipavirus Therapeutics

Bellerophon Therapeutics: Phase 3 REBUILD Trial Fails To Meet Primary Endpoint

CIRCOR Int'l To Be Taken Private By KKR In $1.6 Bln All-cash Deal

Barnes Group To Acquire MB Aerospace

Foghorn : FDA Lifts Clinical Hold On Phase 1 Study Of FHD-286 In Relapsed And/or Refractory AML/MDS

Hoth Therapeutics' Alzheimer's Disease Drug Yields Positive Results In Preclinical Study

Horizon Therapeutics And KPMG Women's Irish Open Form Exclusive Partnership

Foghorn : FDA Lifts Clinical Hold On Phase 1 Study Of FHD-286 In Relapsed And/or Refractory AML/MDS

Inditex Stock Up On Q1 Profit Growth; Sees Flat Margin In FY23

Evotec Gets $1.7 Mln Grant For Discovery Of RNA-targeting Henipavirus Therapeutics

NatWest Completes Sale Of EUR 55.2 Mln Of Shares In Permanent TSB

EU Commissioner Jourova Calls For Labeling Of AI-generated Content

G-III APPAREL Q1 Profit Down, But Beats Estimates; Revises Up Annual Outlook; Stock Up - Update

Paragon Bank H1 Earnings Fall, But Revenues Rise

Frozen RTE Beef Chili Products Supplied Through NSLP Recalled

Accenture Unit Gets $329 Mln Contract From USAID - Quick Facts

Boeing, NASA Further Delay Starliner Crew Flight Launch

Novartis Says Kisqali And Endocrine Therapy Reduces Cancer Recurrence Risk By 25%